Bionor Pharma ASA develops and licenses out vaccines targeted at rapidly-mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed unique patented products for improved health and prevention of lifestyle-related diseases. |